The beating heart of PIAM’s business is the line dedicated to pharmaceuticals, OTX and nutraceuticals.
Founded in 1915 to market the first effective tuberculosis vaccine, PIAM has evolved over time while remaining true to its core values but always focused on the main health and well-being needs of the medical profession and the wider population.
The DNA of PIAM is founded on clearly identified key values: excellence, competence, continuity and responsibility.
These find practical expression in our constant efforts to offer doctors and patients medicines and products that, through innovation in pharmaceutical techniques and formulations, make them easier to administer and use, thereby improving therapeutic adherence.
The beating heart of PIAM’s business is the line dedicated to pharmaceuticals, OTX and nutraceuticals.
Founded in 1915 to market the first effective tuberculosis vaccine, PIAM has evolved over time while remaining true to its core values but always focused on the main health and well-being needs of the medical profession and the wider population.
The DNA of PIAM is founded on clearly identified key values: excellence, competence, continuity and responsibility.
These find practical expression in our constant efforts to offer doctors and patients medicines and products that, through innovation in pharmaceutical techniques and formulations, make them easier to administer and use, thereby improving therapeutic adherence.
Rare or low-prevalence diseases constitute a serious problem for society: they are often debilitating and seriously disabling, potentially lethal and highly complex.
Since they occur with a low frequency, they are not always given the same attention that is paid to other diseases of greater scientific and economic interest. Although, over the last few years, scientific research has made considerable progress, there are still many pathological states that are not adequately known and / or not yet classified.
PIAM has decided to expand its commitment to the treatment of these diseases with a high social impact and which are characterized by a lesser amount of knowledge on the part of both the scientific community and wider society.
Rare or low-prevalence diseases constitute a serious problem for society: they are often debilitating and seriously disabling, potentially lethal and highly complex.
Since they occur with a low frequency, they are not always given the same attention that is paid to other diseases of greater scientific and economic interest. Although, over the last few years, scientific research has made considerable progress, there are still many pathological states that are not adequately known and / or not yet classified.
PIAM has decided to expand its commitment to the treatment of these diseases with a high social
impact and which are characterized by a lesser amount of knowledge on the part of both the scientific community and wider society.
Foods for special medical purposes are products aimed at the dietetic treatment of people suffering from diseases that result in the impossibility or increased difficulty in using ordinary foods to satisfy their nutritional needs.
PIAM has committed itself to these particular dietary needs through a specialized nutritional line: MEDIFOOD.
Foods for special medical purposes are products aimed at the dietetic treatment of people suffering from diseases that result in the impossibility or increased difficulty in using ordinary foods to satisfy their nutritional needs.
PIAM has committed itself to these particular dietary needs through a specialized nutritional line: MEDIFOOD.
